Research study Program year 2020 Source: CMS Open Payments

M14-483

ClinicalTrials.gov NCT02343406

Research payments

$144,909

37 payments

Through program year 2020, $144,909 in research payments was reported against M14-483, across 37 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT02343406

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$96,747	16
2019	Research	$48,162	21

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $144,909 37 payments

Who received the money Research payments · program years 2019–2020

Sarah Cannon Organisation paid for research $61,820 7 payments
University of Colorado Denver School of Medicine Organisation paid for research $27,373 10 payments
Dana-Farber Cancer Institute Teaching hospital · MA $25,297 7 payments
Stanford University Organisation paid for research $11,907 3 payments
Childrens Hospital Colorado Teaching hospital · CO $6,878 4 payments
Upmc Hillman Cancer Center Organisation paid for research $6,385 3 payments
Cleveland Clinic Hospital Teaching hospital · OH $2,000 1 payment
Ut Southwestern Zale Lipshy Pavilion William P Clements Junior University Hospital Organisation paid for research $1,950 1 payment
University Of Texas Southwestern Medical Center At Dallas Organisation paid for research $1,300 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.